Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
ADARX PHARMACEUTICALS, INC. : MORGAN STANLEY INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $32

ADARX PHARMACEUTICALS, INC. : MORGAN STANLEY INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $32

ReutersReuters2026/10/21 10:28
By:Reuters
ADARX PHARMACEUTICALS, INC.
: MORGAN STANLEY INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $32
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!